ES2040323T3 - Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer. - Google Patents

Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer.

Info

Publication number
ES2040323T3
ES2040323T3 ES198888201047T ES88201047T ES2040323T3 ES 2040323 T3 ES2040323 T3 ES 2040323T3 ES 198888201047 T ES198888201047 T ES 198888201047T ES 88201047 T ES88201047 T ES 88201047T ES 2040323 T3 ES2040323 T3 ES 2040323T3
Authority
ES
Spain
Prior art keywords
procedure
therapeutic treatment
senile dementia
preparing compositions
alzheimer type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888201047T
Other languages
English (en)
Inventor
Umberto Cornelli
Thomas A. Ban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Application granted granted Critical
Publication of ES2040323T3 publication Critical patent/ES2040323T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA ADMINISTRACION DE SULFOMUCOPOLISACARIDOS EXTRAIDOS DEL SUODENO O DEL INTESTINO DELGADO DE ANIMALES BOVINOS O DE CERDOS CONDUCE A MEJORAS NOTABLES DE LA SINTOMATOLOGIA CLINICA DE LA DEMENCIA SENIL DE TIPO ALZHEIMER.
ES198888201047T 1987-05-28 1988-05-24 Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer. Expired - Lifetime ES2040323T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Publications (1)

Publication Number Publication Date
ES2040323T3 true ES2040323T3 (es) 1993-10-16

Family

ID=11170725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888201047T Expired - Lifetime ES2040323T3 (es) 1987-05-28 1988-05-24 Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer.

Country Status (8)

Country Link
US (1) US4956347A (es)
EP (1) EP0293974B1 (es)
JP (1) JPS6419021A (es)
AT (1) ATE67666T1 (es)
DE (1) DE3865099D1 (es)
ES (1) ES2040323T3 (es)
GR (1) GR3002802T3 (es)
IT (1) IT1205042B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699968B1 (en) 1989-03-29 2004-03-02 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
ES2059602T3 (es) * 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
ATE311864T1 (de) * 1993-03-29 2005-12-15 Propan-1,3-disulphonsäure und deren pharmazeutisch akzeptable salze zur behandlung von amyloidosis
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
AU3596797A (en) * 1996-07-09 1998-02-02 Keith A. Crutcher Methods for the treatment of apolipoprotein e related diseases
AU9125798A (en) * 1997-08-28 1999-03-16 University Of Washington Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
IL146143A0 (en) * 1999-04-28 2002-07-25 Univ Kingston Compositions and methods for treating amyloidosis
IT1312107B1 (it) 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
EP1828111A2 (en) * 2004-11-12 2007-09-05 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
EP1817305A2 (en) * 2004-11-16 2007-08-15 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
JP5145537B2 (ja) * 2004-12-22 2013-02-20 ビーエイチアイ リミテッド パートナーシップ アミロイド関連疾患を治療するための方法および組成物
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
CN101453999A (zh) * 2005-12-22 2009-06-10 神经化学（国际）有限公司 肾病症、糖尿病肾病和血脂异常的治疗
NZ576285A (en) 2006-10-12 2012-02-24 Bellus Health International Ltd Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
WO2015184231A2 (en) * 2014-05-30 2015-12-03 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
US3007787A (en) * 1960-03-16 1961-11-07 Monsanto Chemicals Butyl xylyl sulfone

Also Published As

Publication number Publication date
DE3865099D1 (de) 1991-10-31
EP0293974B1 (en) 1991-09-25
US4956347A (en) 1990-09-11
IT8720698A0 (it) 1987-05-28
IT1205042B (it) 1989-03-10
EP0293974A1 (en) 1988-12-07
GR3002802T3 (en) 1993-01-25
JPS6419021A (en) 1989-01-23
ATE67666T1 (de) 1991-10-15

Similar Documents

Publication Publication Date Title
ES2040323T3 (es) Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer.
DE3854741D1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
UA13218A (uk) Спосіб одержаhhя заміщеhих імідазолів або їх hетоксичhих фармацевтичhо прийhятhих адитивhих солей
ES2042582T3 (es) Un procedimiento para preparar una composicion de sustancia que tiene una actividad fisiologica y nutricional util.
SE8802569L (sv) Foerbaettringar vid eller avseende somatosstatiner
FI843141A (fi) Nya tillvaexthormon-frigoerande peptider och foerfarande foer behandling av daeggdjur med desamma.
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
FI98125B (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
GB1360462A (en) Isoflavone derivative
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
ES8703894A1 (es) Procedimiento para preparar peptidos liberadores de la hormona del crecimiento
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ES2044848T3 (es) Empleo de extractos de petasita para preparar un medicamento para el tratamiento de enfermedades gastrointestinales.
IL60210A (en) Bis(2-hydroxymethyl-3,4,5-trihydroxy-piperidine)compounds,their production and their use as medicaments and in animal nutrition
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
ES8200363A1 (es) Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
FR2564831B3 (fr) Nouveaux derives des acides aroyl- ou hydroaroyl n-alcoyl pyrrolyl-2 carboxyliques et nouvelles compositions pharmaceutiques a action immuno-suppressive
ES446827A1 (es) Procedimiento de obtencion de una composicion alimenticia para animales.
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
DE3686536D1 (de) Oxytocin und antigestagen zur einleitung der geburt.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 293974

Country of ref document: ES